News

Foundation for Mitochondrial Medicine, UAB and Seahorse Bioscience Form Patient Care Clinical Program

Research efforts behind finding better solutions to mitochondrial diseases are receiving a boost with the newly founded Foundation for Mitochondrial Medicine Program at University of Alabama at Birmingham (UAB). The program was formed by a collaborative partnership between The Foundation for Mitochondrial Medicine (FMM), the University of Alabama at Birmingham (UAB) and Seahorse…

SPG7 Protein Found to Regulate Mitochondria-Induced Cell Death

In a recent study entitled “SPG7 Is an Essential and Conserved Component of the Mitochondrial Permeability Transition Pore”, scientists discovered that the protein SPG7 is the core component of the permeability transition pore (PTP), a structure located in mitochondria membranes, and that it plays a key role…

European Commission Grants Raxone® The First Medicine For Leber’s Hereditary Optic Neuropathy

Santhera Pharmaceuticals, a biopharmaceutical company devoted to the investigation and commercialization of medicines for treating mitochondria and neuromuscular diseases, recently announced that the European Commission granted Raxone® a market authorization in the European Union as the first medicine for the treatment of visual impairment in adolescent and adult patients…

Alcohol Affects Mitochondria Due to Circadian Clock’s Disruption

Researchers may have finally confirmed the widely-held theory that there is a correlation between drinking alcohol and a higher risk of developing mitochondrial disease. New insights reveal that chronic drinking causes damage to the mitochondria, and consequently the liver, due to the effects of alcohol on the liver’s circadian clock.